A Study to Evaluate the Food Effect on Drug Availability, Pharmacokinetic (PK) Properties, Safety and Tolerability of Two Different Dose Combination Therapy of Saxagliptin/Dapagliflozin/Metformin Extended-release (XR) Against Individual Component Co-administration.

Conditions

• Type 2 Diabetes Mellitus

Interventions

• DRUG: 2.5 mg Saxagliptin tablet
• DRUG: 5 mg dapagliflozin / 1000 mg metformin XR tablet
• DRUG: Triple FCDP - 2.5 mg saxagliptin / 5 mg dapagliflozin / 1000 mg metformin XR
• DRUG: 5 mg saxagliptin
• DRUG: 10 mg dapagliflozin / 1000 mg metformin XR tablet
• DRUG: Triple FCDP - 5 mg saxagliptin / 10 mg dapagliflozin / 1000 mg metformin XR

Sponsor

AstraZeneca

Collaborators

• [object Object]